Investors

Overview

Havn Life is focused on the rapidly growing field of psychedelic medicine. We have the opportunity to lead the standardization of psychedelic supply to shift human performance & mental health paradigms. 

Our Team

Collaboration across disciplines

Creating positive patient experiences and mental health outcomes

Vic Neufeld

Executive Chairman

CEO of Aphria for 5 years during large scale build up to one of the leading cannabis producers in the world.

Tim Moore

Chief Executive Officer

Former CEO of Green Growth Brands, from IPO through to Jan 2019, leading the Company to ~$1 Billion market cap.

Gary Leong

Chief Scientific Officer

Former Chief Scientific Officer at Aphria Inc. where he established and oversaw the Quality Assurance, Quality Control, Regulatory Affairs & Research and Development functions.

Gordon Clissold

Chief Financial Officer

Over 20 years of experience as an operational and financial manager, in both public and private companies, with a career experience spanning technology, manufacturing, wholesale distribution, and professional services.

Dr. Ivan Casselman

Chief Psychedelic Officer

Extensive nutraceutical formulation experience, with several products available in legal cannabis markets in North America.

Alexzander Samuelsson

Chief Research Officer

Lead chemist of a publicly traded extraction company, Alexzander developed intellectual property and patented methods in the extraction of cannabis oils.

Jenna Pozar

Chief Operations Officer

18 years of NHP marketing and logistics experience, including Jamieson Wellness and Body Plus. Responsible for the growth and planning for 200+ retail store accounts and three national chains, with a portfolio of eight natural health and performance brands.

Juliana Mollica

Director of Innovation and Quality Assurance

Led projects as the quality assurance and compliance manager for cannabis and pharmaceutical companies to ensure maintenance of GMP requirements, developing QMS for multi-site projects, compliance training programs, and increasing compliance and quality rates.

Rick Brar

Vice Chairman

CEO & Chairman of Brains Bioceutical Corp. A global manufacturer and distributor of Cannabinoid API.

Tim Laidler

Director

Executive Director of the Institute for Veterans Education and Transition at UBC. The institute focuses on supporting the needs of veterans in the community as well as supporting cutting edge research with Veterans.

Havn Life Board

Dennis Staudt

Director

Financial and business expert. As CPA with 22 years as a partner in PricewaterhouseCooper's Audit and Assurance Group. Vice-President of a family-owned farming operation, Staudt Farms.

Allan Oberman

Advisor

Served as CEO for Concordia International, an international speciality pharmaceutical company with sales in 90 countries and over 200 medicines.

Sheila Copps

Advisor

The Honourable Sheila Copps was the first woman to ever hold the position of Deputy Prime Minister and served for ten years in the federal cabinet.

Dr. David Mokler

Advisor

Expert specialist in neuropharmacology, psychopharmacology, substance abuse, drug abuse, brain development, dopamine and serotonin including work relevant to the 5HT2a receptors in psychedelics

David King

Advisor

Drug science and policy expert who received the Dr Abbas Khan Medal by King’s College London for ‘outstanding humanitarian contributions to the service of society’. Also Founder of the Breaking Convention, Europe’s largest academic conference on psychedelic drug research.

Consultants

Legal Counsel

Cassels
cassels.com

Auditor

De Visser Gray LLP
devissergray.com

Transfer Agent

Odyssey Trust Company
odysseytrust.com

CORPORATE PRESENTATION

Or listen to a recorded investor presentation from our CEO, Tim Moore. Email required.

CONTACT INVESTOR RELATIONS

Scroll to Top